Regulation 257E Regulation-making power as to certain forms of labellingF1
The Ministers may by regulations require the use of certain forms of labelling of a medicinal product in order to make it possible to ascertain—
the price of the medicinal product;
any reimbursement conditions of the National Health Service;
the legal status for supply to the patient in accordance with regulation 5 (classification), insofar as not already provided for in Schedule 25;
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations
Textual amendments
- F1
Regs. 257C-257E inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 200 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 154); 2020 c. 1, Sch. 5 para. 1(1)
- F2
Reg. 257E(d) omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 115